A detailed history of Parallel Advisors, LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 1,432 shares of MRVI stock, worth $6,329. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,432
Previous 1,521 5.85%
Holding current value
$6,329
Previous $10,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$6.84 - $9.73 $608 - $865
-89 Reduced 5.85%
1,432 $11,000
Q2 2024

Aug 08, 2024

BUY
$6.87 - $11.34 $487 - $805
71 Added 4.9%
1,521 $10,000
Q1 2024

May 06, 2024

SELL
$5.11 - $8.76 $2,861 - $4,905
-560 Reduced 27.86%
1,450 $12,000
Q4 2023

Feb 09, 2024

BUY
$4.7 - $9.87 $4,239 - $8,902
902 Added 81.41%
2,010 $13,000
Q3 2023

May 20, 2024

BUY
$9.14 - $12.85 $8,938 - $12,567
978 Added 752.31%
1,108 $11,000
Q3 2023

Nov 13, 2023

BUY
$9.14 - $12.85 $8,938 - $12,567
978 Added 752.31%
1,108 $11,000
Q2 2023

May 20, 2024

SELL
$12.09 - $15.0 $10,965 - $13,605
-907 Reduced 87.46%
130 $1,000
Q2 2023

Aug 04, 2023

SELL
$12.09 - $15.0 $10,965 - $13,605
-907 Reduced 87.46%
130 $1,000
Q1 2023

May 20, 2024

SELL
$12.99 - $16.48 $5,364 - $6,806
-413 Reduced 28.48%
1,037 $14,000
Q1 2023

Apr 25, 2023

BUY
$12.99 - $16.48 $2,117 - $2,686
163 Added 18.65%
1,037 $14,000
Q4 2022

Feb 03, 2023

BUY
$12.5 - $24.78 $9,087 - $18,015
727 Added 494.56%
874 $12,000
Q3 2022

Nov 10, 2022

BUY
$20.6 - $30.37 $3,028 - $4,464
147 New
147 $4,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $581M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.